Sudden cardiac death due to ?2-agonist therapy: Is a genetic basis overlooked?

Basit Öğe Kaydı
dc.authorscopusid14322526100
dc.authorscopusid8708323500
dc.authorscopusid6603101290
dc.authorscopusid8898733200
dc.authorscopusid7004009443
dc.contributor.authorYalta K.
dc.contributor.authorSivri N.
dc.contributor.authorGeyik B.
dc.contributor.authorAksoy Y.
dc.contributor.authorYetkin E.
dc.date.accessioned2024-06-12T10:29:18Z
dc.date.available2024-06-12T10:29:18Z
dc.date.issued2012
dc.description.abstract[No abstract available]en_US
dc.identifier.issn1995-1892
dc.identifier.issue2en_US
dc.identifier.pmid22447478en_US
dc.identifier.scopus2-s2.0-84859047411en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17672
dc.identifier.volume23en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofCardiovascular Journal of Africaen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBeta 2 Adrenergic Receptor; Beta 2 Adrenergic Receptor Stimulating Agent; Fenoterol; Sotalol; Adrenergic Stimulation; Arrhythmogenesis; Cardiotoxicity; Catecholaminergic Polymorphic Ventricular Tachycardia; Channelopathy; Drug Fatality; Genetic Susceptibility; Heart Muscle Refractory Period; Human; Letter; Long Qt Syndrome; Pharmacogenetics; Qt Dispersion; Qt Prolongation; Sudden Death; Syncope; T Wave; Torsade Des Pointes; Adrenergic Beta-2 Receptor Agonists; Biomarkers, Pharmacological; Death, Sudden, Cardiac; Electrocardiography; Genetic Predisposition To Disease; Humans; Membrane Potentials; Polymorphism, Genetic; Prognosis; Receptors, Adrenergic, Beta; Signal Transductionen_US
dc.titleSudden cardiac death due to ?2-agonist therapy: Is a genetic basis overlooked?en_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu